Achyut Healthcare MD, chairman, board of directors and AGM
BSE: 543499Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹6.63.
- Under BSE's short-term additional surveillance, stage I, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Next results date: the board meets on 26 Oct 2026 to consider: quarterly results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹168 Cr2,685th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- No recent results
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- No recent results
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, BSEVolume. Shares traded on the last trading day.
- 40,407
Achyut Healthcare board of directors
At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- ChairpersonMAHENDRA CHATRABHUJ RAYCHARelated to the promoter
- Managing directorJIGEN JAGDISHBHAI MODI
8 directors4 independent2 executive2 non-executive
- MAHENDRA CHATRABHUJ RAYCHA · ChairpersonNon-executive · joined Sep 2021 · reappointed Sep 2026 · 2 listed boards · 1 committee seat
- JIGEN JAGDISHBHAI MODI · Managing directorExecutive · joined Jan 2011 · 60 months as independent · 1 listed board · 1 committee seat
- AMISHA JIGEN MODIExecutive · joined Jan 2011 · 60 months as independent · 1 listed board · 1 committee seat
- AKSHIT MAHENDRA RAYCHANon-executive · joined Sep 2021 · 2 listed boards · 2 committee seats, 2 as chair
- RUTVIK SANJAYKUMAR THAKKARIndependent · joined Nov 2021 · 60 months as independent · 2 listed boards · 2 as independent · 2 committee seats, 2 as chair
- SONU LALITKUMAR JAINIndependent · joined Nov 2021 · 60 months as independent · 2 listed boards · 2 as independent · 2 committee seats, 1 as chair
- RAJESH CHINUBHAI SUTARIAIndependent · joined Jul 2025 · 60 months as independent · 6 listed boards · 6 as independent · 5 committee seats, 3 as chair
- PARAG KUMAR SANDIPKUMAR DAVEIndependent · joined Jul 2025 · 60 months as independent · 2 listed boards · 2 as independent · 2 committee seats, 2 as chair
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 5 Sep 20268 of 8 present4 independent · 22 days in between
- 13 Aug 20268 of 8 present4 independent · 77 days in between
- 27 May 20268 of 8 present4 independent
Audit Committee
Chair RUTVIK SANJAYKUMAR THAKKAR
SONULALIT KUMAR JAIN, AKSHIT MAHENDRA RAYCHA
- 13 Aug 20263 of 3 present3 independent · 77 days in between
- 13 Aug 20263 of 3 present3 independent · 77 days in between
- 27 May 20263 of 3 present3 independent
Nomination and remuneration committee
Chair SONULALIT KUMAR JAIN
RUTVIK SANJAYKUMAR THAKKAR, AKSHIT MAHENDRA RAYCHA
- 5 Sep 20263 of 3 present3 independent · 22 days in between
Stakeholders Relationship Committee
Chair AKSHIT MAHENDRA RAYCHA
JIGEN JAGDISHBHAI MODI, AMISHA JIGEN MODI
- 27 May 20263 of 3 present3 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- DOSHI DOSHI & COPeer-review certificate valid to Jan 2029
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Achyut Healthcare AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Achyut Healthcare share news and announcements
Annual general meeting, 29 Sep 2026
3,955 shareholders on the register on 22 Sep 2026; present: 7 promoters and 14 others; votes counted by KAMLESH M SHAH / KAMLESH M SHAH AND COMPANY.The company's voting result (opens in a new tab)
To receive, consider and adopt the financial statements of the Company including the Audited Balance Sheet as on March 31, 2026 the Statement of Profit and Loss and the Cash flow statement for the year ended on that date and the Reports of the Board of Directors and the Auditors of the Company.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 75.20% · promoters 100.00% · institutions 0.00% · other public 58.57%
- To re-appoint Mr. Mahendra C Raycha (DIN: 00577647), who retires by rotation and being eligible offers himself for re-appointment.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 75.20% · promoters 100.00% · institutions 0.00% · other public 58.57%
- Re-appointment Of Mr. Jigen J. Modi (DIN : 03355555), As The "Managing Director" of the Company with Effect From 01st November, 2026 and Ending On 31st October, 2031:Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 75.20% · promoters 100.00% · institutions 0.00% · other public 58.57%
- Re-appointment Of Mrs. Sonu Lalitkumar Jain (Din: 09387661), As A Non-Executive Independent Director of The Company with Effect From 01st November, 2026 and Ending On 31st October, 2031Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 75.20% · promoters 100.00% · institutions 0.00% · other public 58.57%
- Re-appointment Of Mr. Rutvik Sanjaykumar Thakkar (Din: 09387486), As A Non-Executive Independent Director of The Company with Effect From 01st November, 2026 and Ending On 31st October, 2031:Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 75.20% · promoters 100.00% · institutions 0.00% · other public 58.57%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- No
- The chair is related to the managing director
- No
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- No
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.
How money raised was used
Reported for the quarter to Mar 2026. The company's results filing for the quarter to Jun 2026 says no statement of how money raised was used applies to it. A preferential issue sells new shares to chosen investors rather than to the public. A warrant or partly paid issue plans the whole issue while the money comes in over time, so the amount set aside can be more than raised so far.
| Raised | Amount raised | For | Set aside | Spent | Spent elsewhere |
|---|---|---|---|---|---|
| Preferential IssuesMar 2026 | 3.48 | Laboratory Equipment and Furniture | 0.95 | 0.00 | No |
| Preferential IssuesMar 2026 | 3.48 | AHU | 0.40 | 0.02 | No |
| Preferential IssuesMar 2026 | 3.48 | P.U. 60000 Sq. Feet @ Rs.60/- Per Sq. Feet + GST | 0.43 | 0.00 | No |
| Preferential IssuesMar 2026 | 3.48 | Fall Ceiling – Colour – C.P. Fitting and Mirror Civil Work | 0.44 | 0.00 | No |
| Preferential IssuesMar 2026 | 3.48 | S.S. Furniture and Storage Rack | 0.37 | 0.00 | No |
| Preferential IssuesMar 2026 | 3.48 | Office Furniture and Miscellaneous | 0.30 | 0.00 | No |
| Preferential IssuesMar 2026 | 3.48 | General Corporate Purpose | 0.60 | 0.50 | No |